Job Outlook 'Excellent' in Cancer Biotech

Search the Biotechnology Industry Organization's Web site using the keyword "cancer" and you'll come up with pages of companies with at least one product, department, or research program aimed at oncological therapeutics. The late-1998 approval by the Food and Drug Administration (FDA) of Genentech's Herceptin, a monoclonal antibody used to treat metastatic breast cancer, is one attestation to the upswing for biotech cancer products. Typically investment in biotech--and hence hiring--is cyclica

Karen Young Kreeger

| 5 min read

Register for free to listen to this article

Listen with Speechify

0:00

5:00

Share

Search the Biotechnology Industry Organization's Web site using the keyword "cancer" and you'll come up with pages of companies with at least one product, department, or research program aimed at oncological therapeutics. The late-1998 approval by the Food and Drug Administration (FDA) of Genentech's Herceptin, a monoclonal antibody used to treat metastatic breast cancer, is one attestation to the upswing for biotech cancer products.

Typically investment in biotech--and hence hiring--is cyclical. "For example, 1998 to 1999 were very lean years in which the capital markets were not receptive to research," says James Bianco, president and CEO of Seattle-based Cell Therapeutics Inc. "People are now much more receptive to putting fair amounts of capital into earlier stages of research such as genomics. It turns out that cancer and cancer-focused companies have to be one of the hot properties in the life sciences sector right now." Bianco and others describe the job ...

Interested in reading more?

Placeholder Image

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!

Join for free today

Already a member? Login Here

Meet the Author

Karen Young Kreeger
This person does not yet have a bio.
View full profile

Published In

February 2000

Share

Related Research Resources

A greyscale image of cells dividing.

March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Stem Cell Strategies for Skin Repair

Stem Cell Strategies for Skin Repair

In this webinar, Michael Longaker and Maksim Plikus will discuss stem cell approaches for wound healing and skin regeneration.

iStock: Ifongdesign

The Advent of Automated and AI-Driven Benchwork

Discover how new fluidics technologies help scientists make biological breakthroughs through feats of engineering and computational prowess.

Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Learn how mastering the ins and outs of PCR can accelerate workflows and improve data.

3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Molecular detection technologies help scientists rapidly and reliably find and address ever-evolving pathogens with optimal accuracy and sensitivity.

Products

Product News

dispensette-s-group

BRAND® Dispensette® S Bottle Top Dispensers for Precise and Safe Reagent Dispensing

Mounts directly onto most solvent and reagent bottles for faster and more convenient dispensing. Unique design ensures smooth operation and eliminates wearing parts, autoclavable at 121°C. From acids, organic solvents to hydroflouric acids we have a dispenser for you!

Sapio Sciences

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle

New DeNovix Helium Nano Volume Spectrophotometer

DeNovix introduces the Helium 1 µL Spectrophotometer, a new affordable nanovolume spectrophotometer in the DS-Series Quantification Range.

Olink® Reveal: Accessible NGS-based proteomics for every lab

Olink® Reveal is an NGS-based proteomics solution offering high-throughput biomarker analysis with minimal hands-on time. Requiring just 4 µL of sample, it enables deep proteome profiling in 1.5 days, leveraging existing NGS infrastructure for efficient and cost-effective protein analysis.

We’ve updated our Privacy Policy to make it clearer how we use your personal data.

Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.